162
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma

, , , &
Pages 367-371 | Published online: 23 Feb 2015

References

  • WeinrebRNKhawPTPrimary open-angle glaucomaLancet200436394221711172015158634
  • ResnikoffSPascoliniDEtya’aleDGlobal data on visual impairment in the year 2002Bull World Health Organ2004821184485115640920
  • The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study GroupAm J Ophthalmol199812644985059780094
  • Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study GroupAm J Ophthalmol199812644874979780093
  • KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol2002120670171312049574
  • Ostergaard LaursenSBjerrumPTimolol eyedrop-induced severe bronchospasmActa Med Scand198221165055067113767
  • QuarantaLBiagioliERivaIProstaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysisJ Ocul Pharmacol Ther201329438238923231442
  • ShayaFTMullinsCDWongWChoJDiscontinuation rates of topical glaucoma medications in a managed care populationAm J Manag Care2002810 supplS271S27712188170
  • FiscellaRGPersistency with glaucoma medicationAm J Ophthalmol200413861093109415629333
  • DasguptaSOatesVBookhartBKVaziriBSchwartzGFMozaffariEPopulation-based persistency rates for topical glaucoma medications measured with pharmacy claims dataAm J Manag Care2002810 supplS255S26112188168
  • ReardonGSchwartzGFMozaffariEPatient persistency with topical ocular hypotensive therapy in a managed care populationAm J Ophthalmol20041371 supplS3S1214697909
  • Van BuskirkEMThe compliance factorAm J Ophthalmol198610156096103706467
  • Amaral FilhoJMMoreiraRARSilvaSML[Monthly cost of antiglaucomatous drugs in Brazil] Custo mensal de medicações anti-glaucomatosas no BrasilArq Bras Oftalmol199962123126 Portuguese
  • KassMAGordonMMeltzerDWCan ophthalmologists correctly identify patients defaulting from pilocarpine therapy?Am J Ophthalmol198610155245303706456
  • CostaVPVasconcellosJPPelegrinoMKara JoséN[Analysis of the technique of instillation of drops by glaucoma patients] Análise da técnica de instilação do colírio em pacientes glaucomatososRev Bras Oftalmol199554523528 Portuguese
  • SleathBRobinALCovertDByrdJETudorGSvarstadBPatient-reported behavior and problems in using glaucoma medicationsOphthalmology2006113343143616458967
  • SemesLShaikhASEvaluation of the Xal-Ease latanoprost delivery systemOptometry2007781303317208672
  • NordmannJPBaudouinCBronAXal-Ease: impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfactionEur J Ophthalmol200919694995619882583
  • FeinsteinAROn white-coat effects and the electronic monitoring of complianceArch Intern Med19901507137713782369237